36 results about "Chronic cerebral ischemia" patented technology

An application of the medicinal composition composed of ginseng, schisandra fruit, ophiopogon root, red sage root and wolfberry fruit in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of Chuan-xiong rhizome and gastrodia tuber in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the pueraria flavone in preparing the medicines for treating chronic cerebral ischemia is disclosed. Its preparing process includes such steps as providing pueraris roots, extracting in water or alcohol, concentrating, depositing in alcohol, purifying by chromatography, eluting and spray drying.

An application of the medicinal composition composed of 13 Chinese-medicinal materials including notopterygium root, Chuan-xiong rhizome, peach kernel, safflower, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of 18 Chinese-medicinal materials including Chinese angelica root, astragalus root, red peony root, Chuan-xiong rhizome, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of 11 Chinese-medicinal materials including gastrodia tuber, uncaria stem with hooks, scutellaria root, capejasmine, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of 11 Chinese-medicinal materials including Chuan-xiong rhizome, red sage root, gastrodia tuber, borneol, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the gingko leaf's extract (pueraria flavone) in preparing the medicine for treating chronic cerebral ischemia is disclosed. A process for preparing said pueraria flavone is also disclosed.

An application of the medicinal composition composed of astragalus root and anemarrhena rhizome in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of Chuan-xiong rhizome, pueraria root and puncturevine caltrop in preparing the medicine for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of auxiliary choerosponidas fruit, red sage root, cloves, borneol, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention belongs to the field of medicine, and relates to the field of medicine preparation treatment activity. The invention specifically relates to a catalpol and retinoic acid medicine composition CAT-RA and an application thereof in preparing medicines used for preventing and treating with white matter damage after chronic cerebral ischemia. As a result of experiments of CAT-RA in cells and in chronic cerebral ischemia disease animal models, CAT-RA assists in reducing brain tissue inflammatory responses after brain damage, reducing white matter pathological changes, inhibiting oligodendrocyte apoptosis and myelin damage in white matters, and promoting oligodendrocyte precursor cell differentiation and maturation. CAT-RA has the effects of protecting white matters and promoting white matter remyelination. Therefore, CAT-RA can be used as an active component for preparing medicines used for preventing and treating white matter damage after chronic cerebral ischemia, and can also be used for preparing medicines used for treating other cerebral vascular related diseases characterized in white matter damages. The invention provides a novel solution for prevention and treatment of white matter damage related diseases.

An application of the medicinal composition composed of corydalis tube, northern siphonostegia, fortume's drynaria rhizome and ginseng in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention relates to diagnostics, namely to a reagent kit, a rapid method and a device for detecting the fact of chronic, ischemia-linked brain pathology. A special feature of the invention is the use of an immunoactive hybrid peptide produced as a product of two fragments of the NMDA neuroreceptor subunits. A device is described that allows quick and convenient testing of autoantibodies in the patient's blood that recognize the hybrid peptide. The method of detection of autoantibodies is based on the principle of lateral flow immunochromatography. The invention can be used for prophylactic medical examination (screening of chronic ischemia-linked brain lesions), to detect decompensated chronic cerebral ischemia at the prehospital stage by general practitioners or neurologists, as well as in neurosurgery and sports medicine for diagnostics of delayed cerebral ischemia in persons with craniocerebral injury.

An application of the medicinal composition composed of astragalus root and anemarrhena rhizome in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of ginseng and white peony root in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medical composition composed of red sage root, notoginseng and dalbergia wool oil in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of 14 Chinese-medicinal materials including capejasmine fruit, rhubarb, coix seed, earthworm, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The present invention relates to a medicine composition and its application in preparation of medicine for curing chronic cerebral ischemia. Said medicine composition includes 8 Chinese medicinal materials of 10-20 portions of ginseng, 5-15 portions of red peony root, 6-15 portions of centipede, 10-20 portions of scorpion, 20-30 portions of leech, 10-20 portions of wingless cockroach, 10-20 portions of cicada molting and 2-10 portions of borneol.

An application of the medicinal composition composed of Naoyiqin, the extract of notoginseng, VB6 and VE in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention relates to a neural network-based cerebral ischemia risk estimation platform, which comprehensively considers carotid plaque data and brain magnetic resonance images. ) and obviously abnormal plaques (high risk), leaving carotid plaques that are not easy to judge without obvious stenosis, and then use brain magnetic resonance images to break the conventional perception of carotid plaques themselves. Research to explore the relationship between plaque and brain structure, based on neural network modules, can predict carotid plaques from the initial changes of the brain, and estimate the level of cerebral ischemia risk, which can be used for the assessment of cerebral ischemia risk. It is used for the prediction and prevention of acute stroke, chronic cerebral ischemia, vascular dementia, etc. It is used for clinical prediction. It has a very positive effect on prevention before it occurs. It can improve the accuracy of diagnosis and save the disease to a greater extent and in a timely manner. suffer from life.

An application of the medical composition composed of red sage root, gingko leaf, gynostemma pentaphyllum and argyi leaf in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of 8 Chinese-medicinal materials including Chuan-xiong rhizome, red sage root, gastrodia tuber, pueraria root, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of ginseng and white peony root in preparing the medicines for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of notoginseng and gastrodia tuber in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention relates to diagnostics, namely to a reagent kit, a rapid method and a device for detecting the fact of chronic, ischemia-linked brain pathology. A special feature of the invention is the use of an immunoactive hybrid peptide produced as a product of two fragments of the NMDA neuroreceptor subunits. A device is described that allows quick and convenient testing of autoantibodies in the patient's blood that recognize the hybrid peptide. The method of detection of autoantibodies is based on the principle of lateral flow immunochromatography. The invention can be used for prophylactic medical examination (screening of chronic ischemia-linked brain lesions), to detect decompensated chronic cerebral ischemia at the prehospital stage by general practitioners or neurologists, as well as in neurosurgery and sports medicine for diagnostics of delayed cerebral ischemia in persons with craniocerebral injury.

An application of the medicinal composition composed of notoginseng and gastrodia tuber in preparing the medicines for treating chronic cerebral ischemia is disclosed.